XML 113 R23.htm IDEA: XBRL DOCUMENT v3.24.2
Share-based Compensation (Tables)
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]    
Schedule of Estimated Weighted Average Grant Date Fair Value Per Share   The fair values of employee stock options granted in the year ended December 31, 2022 were estimated at the date of grant using the Black-Scholes model with the following assumptions and had the following estimated weighted average grant date fair value per share:
 

Year Ended
December 31,
2022

Expected term

 

 

5.5 years

 

Expected volatility

 

 

107

%

Risk-free interest rate

 

 

3.56

%

Expected dividend yield

 

 

0

%

Weighted-average grant date fair value per share

 

$

1.87

 

Schedule of Stock Option Activities Stock option transactions for the three months ended March 31, 2024 under ARCA’s stock incentive plans were as follows:
 

Options Outstanding

   

Number of
Options

 

Weighted
Average
Exercise
Price

 

Weighted
Average
Remaining
Contractual
Term
(in years)

Options outstanding – December 31, 2023

 

616,707

 

 

$

4.76

 

7.35

Granted

 

42,000

 

 

 

1.64

   

Exercised

 

 

 

 

   

Forfeited and cancelled

 

(12,862

)

 

 

17.45

   

Options outstanding – March 31, 2024

 

645,845

 

 

$

4.30

 

6.82

Options exercisable – March 31, 2024

 

502,517

 

 

$

4.71

 

6.55

Options vested and expected to vest – March 31, 2024

 

645,816

 

 

$

4.30

 

6.82

A summary of ARCA’s stock option activities for the years ended December 31, 2023 and 2022, and related information as of December 31, 2023, is as follows:
 

Options Outstanding

   

Number of
Options

 

Weighted
Average
Exercise
Price

 

Weighted
Average
Remaining
Contractual
Term (in years)

 

Aggregate
Intrinsic Value
(in thousands)

Options outstanding – December 31, 2021

 

904,123

 

 

$

5.59

     

 

 

Granted

 

60,000

 

 

 

2.31

     

 

 

Exercised

 

 

 

 

     

 

 

Forfeited and cancelled

 

(259,163

)

 

 

4.74

     

 

 

Options outstanding – December 31, 2022

 

704,960

 

 

$

5.62

 

8.29

 

$

18

Granted

 

 

 

 

     

 

 

Exercised

 

 

 

 

     

 

 

Forfeited and cancelled

 

(88,253

)

 

 

11.68

     

 

 

Options outstanding – December 31, 2023

 

616,707

 

 

$

4.76

 

7.35

 

$

Options exercisable – December 31, 2023

 

463,068

 

 

$

5.28

 

7.29

 

$

Options vested and expected to vest – December 31, 2023

 

616,661

 

 

$

4.76

 

7.35

 

$

Schedule of RSU Activity   A summary of RSU activity for the year ended December 31, 2023 is presented below:
 

Restricted Stock Units
Outstanding

   

Number of
Shares

 

Weighted
Average
Grant Date
Fair Value

RSUs outstanding – December 31, 2021

 

 

 

$

Granted

 

91,000

 

 

 

2.21

Vested and released

 

 

 

 

Forfeited and cancelled

 

 

 

 

RSUs outstanding – December 31, 2022

 

91,000

 

 

$

2.21

Granted

 

 

 

 

Vested and released

 

(91,000

)

 

 

2.21

Forfeited and cancelled

 

 

 

 

RSUs outstanding – December 31, 2023

 

 

 

$

Schedule of Non-cash, Share-based Compensation Expense For the three months ended March 31, 2024 and 2023, ARCA recognized the following non-cash, share-based compensation expense in the statements of operations (in thousands):
 

Three Months Ended
March 31,

   

2024

 

2023

General and administrative

 

$

114

 

$

163

Research and development

 

 

 

 

41

Total

 

$

114

 

$

204

For the years ended December 31, 2023 and 2022, ARCA recognized the following non-cash, share-based compensation expense (in thousands):
 

Years Ended
December 31,

   

2023

 

2022

General and administrative

 

$

526

 

$

423

Research and development

 

 

160

 

 

133

Total

 

$

686

 

$

556